Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Diorhabda carinata genome sequencing,

PROVIDER: PRJNA889358 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR17229625_subreads.fastq.gz	Fastqsanger.gz
	SRR20379128_1.fastq.gz	Fastqsanger.gz
	SRR20379128_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

Diorhabda carinata

Project description:Diorhabda carinata overview

| PRJNA887509 | ENA

Diorhabda carinata

Project description:Diorhabda carinata genome sequencing, principal pseudohaplotype

| PRJNA788879 | ENA

Diorhabda carinata

Project description:Genome sequencing and assembly of Diorhabda carinata (larger tamarisk beetle) alternate pseudohaplotype

| PRJNA887446 | ENA

Project description:Comparative genomics of Diorhabda carinata, D. carinulata, D. elongata, and D. sublineata

| PRJNA513507 | ENA

Project description:Diorhabda elongata genome sequencing

| PRJNA888121 | ENA

Project description:Diorhabda carinulata genome sequencing

| PRJNA902378 | ENA

Brassica carinata

Project description:Brassica carinata Genome sequencing

| PRJNA952808 | ENA

Brassica carinata

Project description:Brassica carinata Genome sequencing

| PRJNA989515 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Diorhabda sublineata

Project description:Diorhabda sublineata genome sequencing, principal pseudohaplotype

| PRJNA767483 | ENA